September 21, 2010
The European Society of Cardiology (ESC) has welcomed a paper published in the Journal of the American College of Cardiology (JACC) (1) highlighting concerns over the use of oxygen therapy during MI in patients with normal oxygen levels.
September 21, 2010
Short falls with community rehabilitation services are undermining the advances in acute medicine for patients who have suffered a stroke, according to a new report produced by the Royal College of Physicians.
September 21, 2010
A team from the University of Western Ontario have shown that the stress hormone, cortisol, accumulates in human hair and it can be used as a biomarker of risk of acute myocardial infarction (AMI). (1)
September 20, 2010
A new study (1) suggests that persistent dysponea is a robust marker of longer hospitalization and poorer outcomes in patients with acute heart failure.
September 20, 2010
Infections following interventional cardiology procedures are very low but if patients are affected, complications can be life threatening.
September 20, 2010
The National Institute for Health and Clinical Excellence (NICE) has published final guidance on the use of Multaq® (dronedarone) for the treatment of atrial fibrillation (AF).
September 20, 2010
The RealiseAF (Real-life global survey evaluating patients with Atrial Fibrillation) registry show that control of atrial fibrillation (AF) (defined by the 2006 ACC/AHA/ESC AF guidelines as either sinus rhythm or AF with heart rate at rest less than or equal 80 bpm)1 was not achieved in more than 40 percent of the AF patients included in this 10,000 patient cross-sectional registry, as presented today during the European Society of Cardiology Congress in Stockholm, Sweden. In addition, the registry revealed that a majority of patients complain of symptoms, even when AF is controlled 2 (55.7 percent).
September 20, 2010
Atrial Fibrillation, Myocardial Revascularisation and Devices For Heart Failure.
September 20, 2010
The new European Society of Cardiology (ESC)guidelines for the management of atrial fibrillation (AF), have now included guidance on the role of a novel oral treatment, dabigatran etexilate, for the prevention of stroke and systemic embolism in patients with AF (1)
Log in or Register now.
Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.